Risk Factors for Central Serous Chorioretinopathy (Review of Epidemiological Studies)
https://doi.org/10.18008/1816-5095-2019-4-427-432
Abstract
Central serous chorioretinopathy (CSCR) is a chorioretinal pathology characterized by the development of serous detachment of the neurosensory retina, local or multifocal areas of fluid filtration at the level of retinal pigment epithelium with predominant damage to the macular region. The epidemiology of CSCR in the Russian Federation has not been studied. Some authors believe that there is a tendency for increasement the incidence of CSCR.
This article presents the studies results of the influence of various factors on the disease occurrence. CSCR may be associated with various factors, the their contribution to the etiopathogenesis of the disease may be influenced by national and geographical features. All risk factors of CSCR were conditionally divided into chemical (taking different groups of medicines, smoking, alcohol consumption), biological (the presence of somatic or infectious diseases), psychosomatic (stress, sleep disturbance), socio-demographic (gender, age, race, level of education and income). Currently only an increase in the level of corticosteroids in the blood can be considered as a proven risk factor.
Numerous epidemiological studies from around the world show different, often conflicting, data. This makes it difficult to develop methods for the prevention of this disease, and dictates the need for descriptive and analytical epidemiological studies in this direction.
This article presents the studies results of the influence of various factors on the disease occurrence. CSCR may be associated with various factors, the their contribution to the etiopathogenesis of the disease may be influenced by national and geographical features. All risk factors of CSCR were conditionally divided into chemical (taking different groups of medicines, smoking, alcohol consumption), biological (the presence of somatic or infectious diseases), psychosomatic (stress, sleep disturbance), socio-demographic (gender, age, race, level of education and income). Currently only an increase in the level of corticosteroids in the blood can be considered as a proven risk factor.
Numerous epidemiological studies from around the world show different, often conflicting, data. This makes it difficult to develop methods for the prevention of this disease, and dictates the need for descriptive and analytical epidemiological studies in this direction.
About the Authors
D. R. Agliullin
Kazan State Medical University
Russian Federation
Russian Federation
postgraduate of the epidemiology and evidence based medicine Department
Butlerova str., 49, Kazan, 420012, Russian Federation
G. R. Khasanova
Kazan State Medical University
Russian Federation
Russian Federation
MD, PhD, Associate professor, Head of epidemiology and evidence based medicine Department
Butlerova str., 49, Kazan, 420012, Russian Federation
E. A. Abdulaeva
Kazan Branch of Russian Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
PhD, Associate professor of Department of ophthalmology
Mushtari str., 11, Kazan, 420012, Russian Federation
References
1. Salehi M., Wenick A.S., Law H.A., Evans J.R., Gehlbach P. Interventions for central serous chorioretinopathy: a network meta‑analysis (Review). Cochrane Database of Systematic Reviews. 2015;12:137. DOI: 10.1002/14651858.CD011841.pub2
2. Klepinina O.B., Pedanova E.K., Solomin V.A., Bykova M.N. Central serous chorioretinopathy: etiology and pathogenesis. Practical medicine = Prakticheskaya medicina. 2012;4:68–70 (In Russ.)
3. Horniker E. Su di una forma di retinite centrale di origine asoneurotica. Ann. Ottalmol. 1927;55:830–840.
4. Liegl R., Ulbig M.W. Central Serous Chorioretinopathy. Ophthalmologica. 2014;232:65–76. DOI: 10.1159/000360014
5. Tsai D.C., Chen S.J., Huang C.C. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001–2006: a population‑based study. PLoS One. 2013. Available at: https://doi.org/10.1371/journal.pone.0066858 (accessed 12.01.18).
6. Kitzmann A.S., Pulido J.S., Diehl N.N., Hodge D.O., Burke J.P. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmol. 2008;115:169–73. DOI: 10.1016/j.ophtha.2007.02.032
7. Haimovici R., Koh S., Gagnon D.R., Lehrfeld T., Wellik S. Risk factors for central serous chorioretinopathy: a case‑control study. Ophthalmology. 2004;111:244–249. DOI: 10.1016/j.ophtha.2003.09.024
8. Tittl M.K., Spaide R.F., Wong D., Pilotto E., Yannuzzi L.A., Fisher Y.L., Freund B., Guyer D.R., Slakter J.S., Sorenson J.A. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999;128:63–68. DOI: 10.1016/S0002‑9394(99)00075‑6
9. Mansuetta C.C., Mason J.O., Swanner J., Feist R.M., White Jr. M.F., Thomley M.L., McGwin Jr G., Emond T.L. An association between central serous chorioretinopathy and gastroesophageal reflux disease. Am J Ophthalmol. 2004;137:1096–1100. DOI: 10.1016/j.ajo.2004.01.054
10. Nicholson B.P., Atchison E., Idris A.A., Bakri S.J. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. Surv Ophthalmol. 2018;63(1):1–8. DOI: 10.1016/j.survophthal.2017.06.008
11. Chatziralli I., Kabanarou S.A., Parikakis E., Chatzirallis A., Xirou T., Mitropoulos P. Risk factors for central serous chorioretinopathy: multivariate approach in a case‑control study. Current Eye Research. 2017;42(7):1069–1073. DOI: 10.1080/02713683.2016.1276196
12. Carvalho‑Recchia C.A., Yannuzzi L.A., Negrão S., Spaide R.F., Bailey Freund K., Rodriguez‑Coleman H., Lenharo M., Iida T. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109:1834–1837. DOI: 10.1016/S0161‑6420(02)01117‑X
13. Karadimas P., Bouzas E.A. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case–control study. Graefes Arch Clin Exp Ophthalmol. 2004;242:800–802. DOI: 10.1007/s00417‑004‑0885‑z
14. Tsai D.C., Chen S.J., Huang C.C. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population‑based study in Taiwan. Retina. 2014;34:1867–1874. DOI: 10.1097/IAE.0000000000000159
15. Chen S.N., Lian I., Chen Y.C., Ho J.D. Increased incidence of peptic ulcer disease in central serous chorioretinopathy patients: a population‑based retrospective cohort study. Retina. 2015;35:231–237. DOI: 10.1097/IAE.0000000000000278
16. Zhou H., Cai N., Liu M.Z., Cai B. Systematic factors associated with central serous chorioretinopathy. J Tradit Chin Ophthalmol. 2001;11:155.
17. Daruich A., Matet A., Behar‑Cohen F. Central Serous Сhorioretinopathy. Dev Ophthalmol. 2017;58:27–38. DOI: 10.1159/000455267
18. Lahousen T., Painold A., Luxenberger W., Schienle A., Kapfhammer H.P., Ille R. Psychological factors associated with acute and chronic central serous chorioretinopathy. Nord J Psychiatry. 2016;70(1):24–30. DOI: 10.3109/08039488.2015.1041156
19. Bouzas E.A., Scott M.H., Mastorakos G., Chrousos G.P., Kaiser‑Kupfer M.I. Central serous chorioretinopathy in endogenous hypercortisolism. Arch. Ophthalmol. 1993;111:1229–1233. DOI: 10.1001/archopht.1993.01090090081024
20. Harada T., Harada K. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol. 1985;60:37–44.
21. Wong K.H., Lau K.P., Chhablani J., Tao Y., Li Q., Wong I.Y. Central serous chorioretinopathy: what we have learnt so far. Acta Ophthalmol. 2016;94:321–325. DOI: 10.1111/aos.12779
22. Chumbley L.C., Frank R.N. Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974;77(2):158–160. DOI: 10.1016/0002‑9394(74)90667‑9
23. Quillen D.A., Gass D.M., Brod R.D., Gardner T.W., Blankenship G.W., Gottlieb J.L. Central serous chorioretinopathy in women. Ophthalmology. 1996;103:72–79. DOI: 10.1016/S0161‑6420(96)30730‑6
24. Morikawa M., Cho K., Kojima T., Chiba K., Ishikawa S., Umazume T., Nakagawa K., Yamada T., Yamada T., Minakami H. Risk factors for central serous chorioretinopathy in pregnant Japanese women. The journal of obstetrics and gynaecology research. 2017;43(5):866872. DOI: 10.1111/jog.13289
25. Cotticelli L., Borrelli M., D’Alessio A.C. Menzione M, Villani A., Piccolo G., Montella F., Iovene M.R., Romano M. Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol. 2006;16(2):274–278.
26. Marta M.H., Magdalena M., Anna T.K. Helicobacter pylori: a risk factor for the developement of the central serous chorioretinopathy. Klin Oczna. 2009;111:30–32.
27. Rahbani‑Nobar M.B., Javadzadeh A., Ghojazadeh L., Rafeey M., Ghorbanihaghjo A. The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy. Mol Vis. 2011;17:99–103.
28. Casella A.M., Berbel R.F., Bressanim G.L., Malaguido M.R., Cardillo J.A. Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics (Sao Paulo). 2012;67:1047–1052. DOI: 10.6061/clinics/2012(09)11
29. Mateo‑Montoya A., Mauget‑Faÿse M. Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review. World J Gastrointest Pathophysiol. 2014;5(3):355–358. DOI: 10.4291/wjgp.v5.i3.355
30. Eom Y.S., Oh J., Kim S.W., Huh K. Systemic factors associated with central serous chorioretinopathy in Koreans. Korean J Ophthalmol. 2012;26:260–264. DOI: 10.3341/kjo.2012.26.4.260
31. Weenink A.C., Borsje R.A., Oosterhuis J.A. Familial chronic central serous chorioretinopathy. Ophthalmologica. 2001;215:183–187. DOI: 10.1159/000050855
32. Park D.W., Schatz H., Gaffney M.M., McDonald H.R., Johnson R.N., Schaeffer D. Central serous chorioretinopathy in two families. Eur J Ophthalmol. 1998;8:42–47.
33. Yannuzzi L.A. Type‑A behaviour and central serous chorioretinopathy. Retina. 1987;7:111–130.
34. Balashevich L.I., Gacu M.V., Kasimov E.M. Modern concepts of the etiology and pathogenesis of Central serous chorioretinopathy. Ophthalmosurgery = Oftal’mohirurgiya. 2007;2:63–67 (In Russ.)
35. Leveque T.K., Yu L., Musch D.C., Chervin R.D., Zacks D.N. Central serous chorioretinopathy and risk for obstructive sleep apnea. Sleep Breath. 2007;11:253–7. DOI: 10.1007/s11325‑007‑0112‑3
36. Brodie F.L., Charlson E.S., Aleman T.S., Salvo R.T., Gewaily D.Y., Lau M.K., Farren N.D., Engelhard S.B., Pistilli M., Brucker A.J. Obstructive sleep apnea and central serous chorioretinopathy. Retina. 2015;35(2):238–243. DOI: 10.1097/IAE.0000000000000326
37. Rasoulinejad S.A. Central Serous Chorioretinopathy: Epidemiology in Northern Part of Iran. World Applied Sciences Journal. 2015;33(5):843–845. DOI: 10.5829/idosi.wasj.2015.33.05.307
38. Liu B., Deng T., J. Zhang. Risk factors for central serous Chorioretinopathy. A Systematic Review and Meta‑Analysis. The journal of retinal and vitreous diseases. 2016;36(1):9–19. DOI: 10.1097/IAE.0000000000000837
Review
For citations:
Agliullin D.R., Khasanova G.R., Abdulaeva E.A. Risk Factors for Central Serous Chorioretinopathy (Review of Epidemiological Studies). Ophthalmology in Russia. 2019;16(4):427-432. (In Russ.) https://doi.org/10.18008/1816-5095-2019-4-427-432
Views:
3256
Email this article 